January 14, 2009 - Merit Medical Systems Inc. said today that it will enter the microcatheter market with the release of the recently FDA cleared Merit Maestro Microcatheter.
Microcatheters are used to deliver various diagnostic, embolic and therapeutic materials to treat uterine fibroids, hypervascularized tumors and vascular malformations.
“The introduction of this microcatheter product line complements Merit's presence in interventional radiology procedures,'' said Fred P. Lampropoulos, Merit's chairman and CEO. “Many of Merit's existing products can be combined at the same point of sale. Just over a year ago Merit acquired other microcatheter assets and will develop additional products over the next several years.''
The Maestro(tm) microcatheter will be introduced to the U.S. market during the first quarter of 2009.
For more information: www.merit.com
February 16, 2026 
